Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Diclofenac sodium
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dicloflex 75mg SR tablets (Actavis)
1001010C0BQANAL
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex 75mg SR tablets (Kent Pharm)
1001010C0BQAFAL
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex 75mg SR tablets (Teva)
1001010C0BQAEAL
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex Retard 100mg tablets (Almus)
1001010C0BQAMAF
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex Retard 100mg tablets (Kent Pharm)
1001010C0BQAHAF
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dicloflex Retard 100mg tablets (Teva)
1001010C0BQAGAF
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclotard 75mg modified-release tablets
1001010C0BZAAAL
|
Diclotard | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol 25mg gastro-resistant tablets
1001010C0CCAAAD
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol 50mg gastro-resistant tablets
1001010C0CCABAE
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol 75mg SR tablets (Arun Pharm)
1001010C0CCACAL
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol 75mg SR tablets (Mylan)
1001010C0CCAEAL
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol Retard 100mg tablets (Arun Pharm)
1001010C0CCADAF
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclovol Retard 100mg tablets (Mylan)
1001010C0CCAFAF
|
Diclovol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclozip 25mg gastro-resistant tablets
1001010C0BIAAAD
|
Diclozip | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Diclozip 50mg gastro-resistant tablets
1001010C0BIABAE
|
Diclozip | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dyloject 75mg/2ml solution for injection vials
1001010C0CLAABI
|
Dyloject | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Econac 75mg/3ml solution for injection ampoules
1001010C0CFABAA
|
Econac | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Econac SR 75mg tablets
1001010C0CKAAAL
|
Econac | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Econac XL 100mg tablets
1001010C0CKABAF
|
Econac | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Enstar SR 75 tablets
1001010C0CMAAAL
|
Enstar | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Enstar XL 100 tablets
1001010C0CMABAF
|
Enstar | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Fenactol 25mg gastro-resistant tablets
1001010C0CJAAAD
|
Fenactol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamatak MR 100mg tablets
1001010C0BYAAAF
|
Flamatak | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamatak MR 75mg tablets
1001010C0BYABAL
|
Flamatak | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamrase 25 EC tablets
1001010C0BKAAAD
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.